Introduction
============

Ethylenediaminetetraacetic acid (EDTA) ([Fig. 1](#f1-aci-2011-007){ref-type="fig"}) is a powerful chelating agent, forming stable complexes with most metal ions. Due to its ability to sequester metal ions, EDTA is widely used in medicine, chemical industry, food technology, agriculture and pharmaceutical technology. EDTA in its disodium salt or calcium disodium salt form is frequently used in pharmaceuticals because of its stability, compatibility and low toxicity. In the field of analytical chemistry, besides its use in complexometric titrations, EDTA has been reported to be very useful ligands for the complexation of metals, which enables their chromatographic separations.[@b1-aci-2011-007]

Meropenem is an ultra-broad spectrum injectable antibiotic used to treat a wide variety of infections, including meningitis and pneumonia. It is a betalactam and belongs to the subgroup of carbapenem, similar to imipenem and ertapenem. EDTA is being used in the synthesis of Meropenem. Therefore the quantification of the residual EDTA is essential as per regulatory requirement.

Various analytical methods have been proposed for the determination of EDTA in a wide variety of sample matrices.[@b2-aci-2011-007] They include titrimetry,[@b3-aci-2011-007] spectrophotometry, [@b4-aci-2011-007] electrochemistry eg, polarography,[@b5-aci-2011-007] differential pulse polorography,[@b6-aci-2011-007] catalytic potential tirtrimetry,[@b7-aci-2011-007] differential pulse anodic stripping voltammetry,[@b8-aci-2011-007] amperometry,[@b9-aci-2011-007] capillary electrophoresis,[@b10-aci-2011-007] and chromatography. Among them, gas chromatography and HPLC (reverse phase ion-pair or ion exchange retention mechanism) appear to be the prevailing techniques, despite the fact that EDTA lacks volatility and exhibits low UV/visible absorptivity. The gas chromatographic methods always include a time consuming derivatization steps, in which EDTA is converted into methyl, ethyl, propyl and butyl esters to obtained volatility.[@b11-aci-2011-007],[@b12-aci-2011-007]

This paper describes development and validation of derivatized method with direct UV-detection for the quantitative determination of disodium EDTA in Meropenem drug substance. This method also has advantages over some techniques as mentioned in above references,[@b3-aci-2011-007]--[@b12-aci-2011-007] like here EDTA response is measured by direct UV detection with enhanced sensitivity and method is simpler, highly reproducible, specific and accurate, compare to using complex techniques like titrimetry, spectrophotometric, capillary electrophoresis or GC technique. As EDTA does not contain any chromophoric group, it is very difficult to determine EDTA by direct UV detection. Hence a method has been optimized and developed by derivatizing disodium EDTA with ferric chloride solution. The method has been optimized with respect to reaction time, derivatization temperature and derivatization reagent volume and suitably validate for its intended use.

Experimental
============

Reagents and chemicals
----------------------

Di-sodium salt of Ethylenediaminetetra-acetic acid dehydrate was purchased form Qualigens, Sodium acetate trihydrate was purchased from Qualigens (AR grade), Tetra butyl ammonium bromide was purchased from Spectrochem (AR grade), Methanol (HPLC grade), Acetic acid glacial was purchased from Rankem (AR grade), Ferric chloride anhydrous was purchased from Qualigens (AR grade) and Meropenem was obtained from Ranbaxy Labs. Ltd. (India). All the above materials were used without any further purification. Water (HPLC grade) was used for the preparation of solutions.

Chromatography
--------------

The analytical separations were carried out on a Waters HPLC system, equipped with a 2695 separation module and 2996 photodiode array detector. The analytical column was a Phenomenex Luna C18 (2) column (250 × 4.6 mm), 5 μ. The mobile phase consisted of premixed and degassed solution of buffer and methanol in the ratio of \[95:5\] \[v/v\]. Mobile phase was prepared by dissolving 4.1 gm of sodium acetate trihydrate and 0.64 gm Tertrabutyl ammonium bromide in 950 mL of water and than added 50 mL of methanol, mixed and pH adjusted to 4.0 with acetic acid glacial. The mobile phase was filtered through a 0.45 μm membrane filter. Water used as a diluent for the preparation of solutions. The flow rate was 1 mL/min and runtime was 10 minute for EDTA standard solution and 60 minutes for Meropenem sample solutions. Column temperature was maintained at 30 °C. UV detection was measured at 254 nm and the volume of sample injected was 100 μL. The control of the HPLC system and data collection was by Empower software.

Derivatization process of standard and sample solution
------------------------------------------------------

### Standard solution preparation

A standard stock solution at 1 milligram per milliliter (mg/mL) was prepared by dissolving disodium salt of EDTA in diluent (Accurately weighed and disolved disodium salt of EDTA dihydrate 63.5 mg equivalent to 50 mg of EDTA in 50 mL of diluent). The derivatization process was carried out by transferring 10 mL of standard stock solution into 100 mL volumetric flask. Add 5 mL of Ferric chloride solution (About 0.64 gm of Ferric chloride anhydrous transfer to 200 mL volumetric flask and dissolve with 5 Ml 1 N solution of hydrochloric acid and make up the volume to 200 mL with water). Shake well and keep in water bath at 70 °C for 20 minutes, finally make-up the volume with diluent after it attains room temperature. Dilute the solution with diluent to achieve the final concentration 0.0002 mg/mL.

### Sample solution preparation

A sample solution was prepared by dissolving 500 mg of Meropenem sample in diluent, in 25 mL volumetric flask. The derivatization process was carried out by adding 2 mL of Ferric chloride solution. Shake well and keep in water bath at 70 °C for 20 minutes, finally make-up the volume with diluent after it attains room temperature. The final concentration is 20 mg/mL.

Results and Discussion
======================

Method validation
-----------------

### Specificity

Blank, sample solution and sample solution spiked with EDTA (at 0.001% of sample concentration) along with other known related substances of Meropenem were chromatographed individually as per the method to examine interference, if any, with EDTA peak.

No peak from the blank was observed at the retention time of EDTA peak. The peak purity plot of EDTA shows that the peak is pure and has no co eluting peaks, indicating specificity of the method ([Figs. 2](#f2-aci-2011-007){ref-type="fig"}--[4](#f4-aci-2011-007){ref-type="fig"}).

### Linearity of response

The linearity of response for EDTA was determined in the range as given in [Table 1](#t1-aci-2011-007){ref-type="table"}. Data shown in [Table 1](#t1-aci-2011-007){ref-type="table"} indicates that the response is linear over the specified range. (Acceptance criteria: Correlation coefficient should not be less than 0.98).

### Precision

#### System precision

Standard solution was injected six times into the HPLC system. Data shown in [Table 2](#t2-aci-2011-007){ref-type="table"} indicate an acceptable level of precision for the analytical system. (Acceptance criteria: RSD should not be more than 5.0%).

#### Method precision

Six samples of a single batch of Meropenem API were prepared and analysed by the proposed method. Data is shown in [Table 3](#t3-aci-2011-007){ref-type="table"}. The % RSD value indicates that the method has an acceptable level of precision (Acceptance criteria: RSD should not be more than 10%).

#### Accuracy

Known amount of sample was taken separately into nine different flasks and spiked with known quantities of EDTA at three different levels, each in triplicate. The samples were analysed by the proposed method and the amount of EDTA recovered after making corrections for the amount already present were calculated. Data shown in [Table 4](#t4-aci-2011-007){ref-type="table"} indicate that the method has an acceptable level of accuracy. (Acceptance criteria: Recovery should be in the range of 80%--120%).

#### Ruggedness

Ruggedness of the method was verified by analysing samples of a single batch of Meropenem API by two different analysts using two different instruments and columns on different days. The mean, standard deviation and % RSD for EDTA is shown in [Table 5](#t5-aci-2011-007){ref-type="table"}. Ruggedness of the method is shown by the overall RSD value of 4.87% between the two sets of data. (Acceptance criteria: Overall RSD should not be more than 10%).

#### Stability in analytical solution

A sample solution of Meropenem API was prepared and kept at 10 °C. The sample solution was analysed initially and at various time intervals. Data is shown in [Table 6](#t6-aci-2011-007){ref-type="table"}. As the cumulative % RSD up to 975 min. for EDTA meets the acceptance criteria, it is concluded that sample is stable in analytical solution at 10 °C for about 16 h. (Acceptance criteria: Cumulative RSD should not be more than 10%).

#### Limit of quantitation and detection

The limit of quantitation and detection for EDTA were determined from linearity data using the formulae\* and verifying the predicted LOQ and LOD values by showing precision by making six replicate injections of lower concentration solutions of EDTA. Data is shown in [Table 7a](#t7a-aci-2011-007){ref-type="table"} and summarized in [Table 7b](#t7b-aci-2011-007){ref-type="table"}. (Acceptance criteria: RSD should not be more than 10% for LOQ and should not be more than 33% for LOD).

#### Robustness

Robustness of the method was investigated by varying the instrumental conditions such as flow rate (±10%), column oven temperature (35 °C), organic content in mobile phase (±2%), wavelength of detection (±5 nm) and pH of mobile phase (±0.2). Sample solution was analysed under each condition and EDTA content was calculated. The mean, standard deviation and % RSD for each set of data are shown in [Table 8](#t8-aci-2011-007){ref-type="table"}. Robustness of the method is indicated by the overall % RSD between the data of Set I and data at each variable condition. However, under the condition of Temperature (35 °C), change in organic content in mobile phase (±2%) and change in pH of mobile phase (±0.2%), the % RSD is above the acceptance criterion. Hence it is recommended to adhere to the method. (Acceptance criteria: Overall RSD should not be more than 10%).

Conclusion
==========

A simple isocratic reverse phase method for the determination of EDTA was developed and validated using direct UV detection. The method is selective, precise and accurate and was successfully applied to the analysis of commercially available Meropenem drug substances. EDTA is not easily detected by HPLC using UV detection because of absence of a chromophoric group. Derivatization with Ferric chloride solution is a simple and very effective means of enhancing the chromatographic detection of the compound.
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###### 

Linearity of response.

  **Conc. (μg/mL)**   **Area counts (μV\*sec.)**
  ------------------- ----------------------------
  0.035               6072
  0.058               10390
  0.116               18963
  0.231               36709
  0.347               55300
  0.579               92690
  1.157               186442
  2.315               359162
  3.472               549143
  Slope               157156
  Intercept           989
  CC                  0.99991

**Abbreviation:** CC, Correlation coefficient.

###### 

System precision.

  **Injection No.**   **Area counts (μV\*sec.)**
  ------------------- ----------------------------
  1                   36737
  2                   36288
  3                   36640
  4                   36710
  5                   36548
  6                   36699
  Mean                36604
  SD                  169
  RSD (%)             0.46

###### 

Method precision.

  **Sample No.**   **EDTA (ppm)**
  ---------------- ----------------
  1                8.078
  2                7.908
  3                7.791
  4                7.456
  5                7.276
  6                7.108
  Mean             7.603
  SD               0.3815
  RSD (%)          5.02

###### 

Accuracy.

  **Recovery level**   **EDTA**             
  -------------------- ---------- --------- -------
  Level-1, Rec 1       58.009     53.783    92.71
  Level-1, Rec 2       57.840     53.656    92.77
  Level-1, Rec 3       57.817     52.790    91.31
  Level-2, Rec 1       115.372    108.048   93.65
  Level-2, Rec 2       115.609    107.659   93.12
  Level-2, Rec 3       113.896    104.715   91.94
  Level-3, Rec 1       232.650    217.232   93.37
  Level-3, Rec 2       231.172    215.982   93.43
  Level-3, Rec 3       232.197    218.217   93.98
  Mean                                      92.92
  SD                                        0.850
  RSD (%)                                   0.91

###### 

Ruggedness.

  **Sample No.**    **Disodium EDTA (ppm)**   
  ----------------- ------------------------- --------
  1                 8.078                     8.466
  2                 7.908                     8.027
  3                 7.791                     7.859
  4                 7.456                     7.926
  5                 7.276                     7.963
  6                 7.108                     7.513
  Mean              7.603                     7.959
  SD                0.3815                    0.3071
  RSD (%)           5.02                      3.86
  Overall Mean      7.781                     
  Overall SD        0.3790                    
  Overall RSD (%)   4.87                      
  Set               I                         II
  Analyst           1                         2
  Instrument No.    A                         B
  Column No.        X                         Y

###### 

Stability in analytical solution (At 10 °C).

  **Time (min.)**   **Area counts (μV\*sec.)**   **Cumulative RSD (%)**
  ----------------- ---------------------------- ------------------------
  Initial           23892                        --
  61                23629                        0.78
  123               23455                        0.93
  184               23145                        1.33
  246               23756                        1.23
  307               23244                        1.24
  369               22678                        1.77
  490               21361                        3.53
  611               21230                        4.34
  732               20521                        5.33
  854               19465                        6.72
  975               18146                        8.56

###### 

Limit of quantitation and detection.

  **Conc.**   **LOQ**                  **LOD**
  ----------- ------------------------ ---------
  μg/mL       0.034                    0.023
  ppm         1.700                    1.150
  Injection   Area counts (μV\*sec.)   
  1           5901                     4415
  2           5849                     4793
  3           6034                     3695
  4           5930                     5378
  5           5578                     4291
  6           5649                     4813
  Mean        5824                     4564
  SD          175                      571
  RSD (%)     3.00                     12.51

###### 

Summary of LOQ and LOD values.

  **S.no.**                                                                                                                           **Component**   **LOQ**   **LOD**           
  ----------------------------------------------------------------------------------------------------------------------------------- --------------- --------- --------- ------- -------
  1                                                                                                                                   EDTA            0.034     1.700     0.023   1.150
                                                                                                                                                                                  
  \* $\begin{array}{l}                                                                                                                                                            
  {\text{LOQ}\,(\mu\text{g}/\text{mL}) = \frac{10\, \times \,\text{Residual}\,\text{standard}\,\text{deviation}}{\text{Slope}}} \\                                                
   \\                                                                                                                                                                             
  \end{array}$                                                                                                                                                                    
  \* $\text{LOD}\,(\mu\text{g}/\text{mL}) = \frac{3.3\, \times \,\text{Residual}\,\text{standard}\,\text{deviation}}{\text{Slope}}$                                               

###### 

Robustness.

  **S.no.**         **EDTA (ppm)**                                                                           
  ----------------- ---------------- -------- -------- -------- -------- -------- -------- -------- -------- --------
  1                 8.078            7.948    8.201    8.274    8.037    9.505    17.146   22.761   22.067   12.021
  2                 7.908            7.889    8.135    7.765    7.688    10.520   18.165   23.884   24.582   14.773
  3                 7.791            7.753    8.119    8.206    7.511    7.561    17.459   20.609   22.260   11.461
  4                 7.456            --       --       --       --       --       --       --       --       --
  5                 7.276            --       --       --       --       --       --       --       --       --
  6                 7.108            --       --       --       --       --       --       --       --       --
  Mean              7.603            7.863    8.152    8.082    7.745    9.195    17.590   22.418   22.970   12.752
  SD                0.3815           0.1000   0.0435   0.2763   0.2676   1.5036   0.5220   1.6642   1.3997   1.7728
  RSD (%)           5.02             1.27     0.53     3.42     3.46     16.35    2.97     7.42     6.09     13.90
  Overall Mean      7.690            7.786    7.762    7.650    8.134    10.932   12.541   12.725   9.319    
  Overall SD        0.3323           0.4083   0.4091   0.3375   1.1359   5.0095   7.4603   7.7211   2.7394   
  Overall RSD (%)   4.32             5.24     5.27     4.41     13.96    45.82    59.49    60.68    29.40    

**Notes:** Set I---Control (Proposed method); Set II---Variation in wavelength (UV = 249 nm); Set III---Variation in wavelength (UV = 259 nm); Set IV--- Variation in flow rate (−10%); Set V---Variation in flow rate (+10%); Set VI---Column oven temperature (35 °C); Set VII---Variation in organic content in mobile phase (−2%); Set VIII---Variation in organic content in mobile phase (+2%); Set IX---Variation in pH of mobile phase (−0.2); Set X---Variation in pH of mobile phase (+0.2).
